Analysts/Institutional Investor Meet/Con. Call Updates

Ref: Akums/Exchange/2026-27/50 September 23, 2026 To, To, The Listing Department The Listing Department National Stock Exchange of India Ltd. BSE Limited Exchange Plaza, C-1, Block G, 25th Floor, New Trading Ring, Bandra Kurla Complex, Rotunda Building, Phiroze Jeejeebhoy Bandra (E), Mumbai – 400 051 Towers, Dalal Street, Mumbai – 400 001 Symbol: AKUMS Scrip Code: 544222 Sub: Intimation of Schedule of the Institutional Investors Meets Respected Sir/Ma’am, This is to inform you that pursuant to Regulation 30 read with Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Akums Drugs and Pharmaceuticals Limited (“the Company”) will participate in the below mentioned institutional investors meets: S. No. Particulars of Meet Date & Time of Type of Meet Location / Mode Meeting of Meeting 1. Institutional Investor 28th September, Multiple One on Mumbai/ Physical Meeting 2026; starts at 09:00 One & Group AM (IST) onwards Meetings 2. Institutional Investor 29th September, Multiple One on Mumbai/ Physical Meeting 2026; starts at 09:00 One & Group AM (IST) onwards Meetings Further, no unpublished price sensitive information pertaining to the Company will be shared during the meet with Investors. Please note that the above may subject to change due to exigencies on the part of Investors or the Company. A copy of this disclosure is being updated on website of the Company at www.akums.in This is for your information and records. For Akums Drugs and Pharmaceuticals Limited Dharamvir Malik Company Secretary & Compliance Officer